Retinoid receptor (RAR/RXR)

Retinoid receptors are a family of nuclear receptors that mediate the biological effects of vitamin A and its derivatives, known as retinoids. They are categorized into two main subfamilies: Retinoic Acid Receptors (RARs) and Retinoid X Receptors (RXRs), each comprising alpha, beta, and gamma isoforms. These receptors act as transcription factors that, upon ligand binding, regulate the expression of a vast array of genes involved in essential processes such as embryonic development, cell differentiation, and immune function. In a clinical context, they are major therapeutic targets for dermatological conditions like acne and psoriasis, as well as hematologic malignancies, specifically acute promyelocytic leukemia (APL), where tretinoin induces the differentiation of leukemic promyelocytes. Despite their high efficacy, drugs targeting these receptors are strictly regulated due to their potent teratogenic effects and potential for systemic toxicity (Source: UniProt, P10276; NIH, National Cancer Institute).

Other names

Retinoic acid receptorRetinoid X receptorNuclear retinoid receptorRARRXR

Retinoid receptors function as ligand-activated transcription factors. Upon binding of a retinoid ligand (such as all-trans retinoic acid or 9-cis retinoic acid), Retinoic Acid Receptors (RARs) typically form heterodimers with Retinoid X Receptors (RXRs). These dimers bind to specific DNA sequences called Retinoic Acid Response Elements (RAREs) in the promoter regions of target genes, recruiting co-activators and inducing the transcription of genes that regulate cell growth, differentiation, and apoptosis (Source: PubMed, PMID: 24530788; StatPearls, NBK541005).